157 related articles for article (PubMed ID: 36031142)
1. Intracellular glutathione levels affect the outcomes of verteporfin-mediated photodynamic therapy in esophageal cancer cells.
Edano M; Kanda T; Tarumoto R; Hamamoto W; Hasegawa T; Mae Y; Onoyama T; Takata T; Sugihara T; Isomoto H
Photodiagnosis Photodyn Ther; 2022 Dec; 40():103090. PubMed ID: 36031142
[TBL] [Abstract][Full Text] [Related]
2. In-Vitro Use of Verteporfin for Photodynamic Therapy in Glioblastoma.
Jeising S; Geerling G; Guthoff R; Hänggi D; Sabel M; Rapp M; Nickel AC
Photodiagnosis Photodyn Ther; 2022 Dec; 40():103049. PubMed ID: 35932958
[TBL] [Abstract][Full Text] [Related]
3. Carrier-Free, Amorphous Verteporfin Nanodrug for Enhanced Photodynamic Cancer Therapy and Brain Drug Delivery.
Quinlan JA; Inglut CT; Srivastava P; Rahman I; Stabile J; Gaitan B; Arnau Del Valle C; Baumiller K; Gaur A; Chiou WA; Karim B; Connolly N; Robey RW; Woodworth GF; Gottesman MM; Huang HC
Adv Sci (Weinh); 2024 May; 11(17):e2302872. PubMed ID: 38445882
[TBL] [Abstract][Full Text] [Related]
4. Combination of Molecule-Targeted Therapy and Photodynamic Therapy Using Nanoformulated Verteporfin for Effective Uveal Melanoma Treatment.
Song M; Zhu L; Zhang L; Ge X; Cao J; Teng Y; Tian R
Mol Pharm; 2024 May; 21(5):2340-2350. PubMed ID: 38546166
[TBL] [Abstract][Full Text] [Related]
5. A next-generation bifunctional photosensitizer with improved water-solubility for photodynamic therapy and diagnosis.
Nishie H; Kataoka H; Yano S; Kikuchi JI; Hayashi N; Narumi A; Nomoto A; Kubota E; Joh T
Oncotarget; 2016 Nov; 7(45):74259-74268. PubMed ID: 27708235
[TBL] [Abstract][Full Text] [Related]
6. X-ray radiation-induced and targeted photodynamic therapy with folic acid-conjugated biodegradable nanoconstructs.
Clement S; Chen W; Deng W; Goldys EM
Int J Nanomedicine; 2018; 13():3553-3570. PubMed ID: 29950835
[TBL] [Abstract][Full Text] [Related]
7. Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice.
Hu Z; Rao B; Chen S; Duanmu J
BMC Cancer; 2010 May; 10():235. PubMed ID: 20504328
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis and autophagy induced by DVDMs-PDT on human esophageal cancer Eca-109 cells.
Shi Y; Zhang B; Feng X; Qu F; Wang S; Wu L; Wang X; Liu Q; Wang P; Zhang K
Photodiagnosis Photodyn Ther; 2018 Dec; 24():198-205. PubMed ID: 30268863
[TBL] [Abstract][Full Text] [Related]
9. Verteporfin- and sodium porfimer-mediated photodynamic therapy enhances pancreatic cancer cell death without activating stromal cells in the microenvironment.
Lu J; Roy B; Anderson M; Leggett CL; Levy MJ; Pogue B; Hasan T; Wang KK
J Biomed Opt; 2019 Nov; 24(11):1-11. PubMed ID: 31741351
[TBL] [Abstract][Full Text] [Related]
10. Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines.
Celli JP; Solban N; Liang A; Pereira SP; Hasan T
Lasers Surg Med; 2011 Sep; 43(7):565-74. PubMed ID: 22057484
[TBL] [Abstract][Full Text] [Related]
11. Nano-Photosensitizer Directed Targeted Phototherapy Effective Against Oral Cancer in Animal Model.
Yu L; Zhu G; Zhang Z; Xu Z; Peng W; Zeng L; Yu Y; Wang S; Lin Z; Zhang X; Zhou N; Zhang L; Liang L
Int J Nanomedicine; 2023; 18():6185-6198. PubMed ID: 37933297
[TBL] [Abstract][Full Text] [Related]
12. Core-matched nanoassemblies for targeted co-delivery of chemotherapy and photosensitizer to treat drug-resistant cancer.
Jiang D; Xu M; Pei Y; Huang Y; Chen Y; Ma F; Lu H; Chen J
Acta Biomater; 2019 Apr; 88():406-421. PubMed ID: 30763634
[TBL] [Abstract][Full Text] [Related]
13. Verteporfin-photodynamic therapy is effective on gastric cancer cells.
Mae Y; Kanda T; Sugihara T; Takata T; Kinoshita H; Sakaguchi T; Hasegawa T; Tarumoto R; Edano M; Kurumi H; Ikebuchi Y; Kawaguchi K; Isomoto H
Mol Clin Oncol; 2020 Sep; 13(3):10. PubMed ID: 32754324
[TBL] [Abstract][Full Text] [Related]
14. Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer.
Banerjee SM; Acedo P; El Sheikh S; Harati R; Meecham A; Williams NR; Gerard G; Keshtgar MRS; MacRobert AJ; Hamoudi R
Front Immunol; 2023; 14():1188087. PubMed ID: 38022682
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy in retinoblastoma: effects of verteporfin on retinoblastoma cell lines.
Stephan H; Boeloeni R; Eggert A; Bornfeld N; Schueler A
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3158-63. PubMed ID: 18579764
[TBL] [Abstract][Full Text] [Related]
16. Comparison between endothelial and tumor cells in the response to verteporfin-photodynamic therapy and a PI3K pathway inhibitor.
Fateye B; Wan A; Yang X; Myers K; Chen B
Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):19-26. PubMed ID: 25636781
[TBL] [Abstract][Full Text] [Related]
17. In vitro effects of verteporfin on ocular cells.
Ammar DA; Kahook MY
Mol Vis; 2013; 19():424-9. PubMed ID: 23441114
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Enhancement of Verteporfin-mediated Photodynamic Therapy by mTOR Inhibitors.
Kraus D; Palasuberniam P; Chen B
Photochem Photobiol; 2020 Mar; 96(2):358-364. PubMed ID: 31769520
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Study of Antineoplastic Sinoporphyrin Sodium-PDT via In Vitro and In Vivo Models.
Shi R; Li C; Jiang Z; Li W; Wang A; Wei J
Molecules; 2017 Jan; 22(1):. PubMed ID: 28085075
[TBL] [Abstract][Full Text] [Related]
20. The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation.
Brodowska K; Al-Moujahed A; Marmalidou A; Meyer Zu Horste M; Cichy J; Miller JW; Gragoudas E; Vavvas DG
Exp Eye Res; 2014 Jul; 124():67-73. PubMed ID: 24837142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
